Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
uniQure is a leading biotechnology company based in the Netherlands, specializing in the development of innovative gene therapies. The company focuses on the treatment of severe genetic diseases through advanced methods of molecular medicine to transform the lives of patients worldwide.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
uniQure is scheduled to report its next quarterly earnings on 11/10/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
uniQure last reported quarterly earnings on 7/29/2026 (Q2 2026). Earnings per share (EPS) came in at -1.22 USD.
uniQure has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.